Fundz

Appili Therapeutics Announces Additional Funding for Its ATI-1701 Biodefense Program

PRIVATEOct 27, 2020

Amount Raised

$6 Million

Round Type

Funding Round

HalifaxBiotechnologyHealth CareScience And Engineering

Description

Appili Therapeutics Inc. (TSX: APLI; OTCQX: APLIF) (the Company or Appili), a biopharmaceutical company developing anti-infective drug candidates, today announced updates for the continued development of its ATI-1701 biodefense vaccine program. Appili has entered into an agreement with Ology Biosciences, a biologics contract development and manufacturing organization (CDMO), under which Ology will manufacture ATI-1701, a novel live attenuated tularemia vaccine candidate. The U.S

Quick answer

Appili Therapeutics Inc. raised $6 Million in a Funding Round round, dated October 27, 2020. Appili Therapeutics Inc. is based in Halifax, England, United Kingdom.

How much did Appili Therapeutics Inc. raise?
Appili Therapeutics Inc. raised $6 Million in a Funding Round round on October 27, 2020.
What does Appili Therapeutics Inc. do?
Appili Therapeutics is an infectious disease biopharmaceutical company that is purposefully built, portfolio-driven, and people-focused to fulfill its mission of solving life-threatening infections.
Where is Appili Therapeutics Inc. based and how big is it?
Appili Therapeutics Inc. is based in Halifax, England, United Kingdom.

Source: Fundz verified event record.

Who else raised in Science And Engineering and Biotechnology around the same time

Companies in the same sectors as Appili Therapeutics Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Viracta Therapeutics raised $40M on December 10, 2020.
  • Geneos Therapeutics raised $10M on November 17, 2020.
  • Memo Therapeutics AG raised an undisclosed amount (Series B) on November 6, 2020.
  • Unlearn raised an undisclosed amount (Series A) on November 5, 2020.
  • Bond Biosciences raised $3.1M on November 4, 2020.
  • Dewpoint Therapeutics raised $77M on November 2, 2020.

Who to call at Appili Therapeutics Inc., and when

A new round usually means Appili Therapeutics Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Appili Therapeutics Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Appili Therapeutics Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Appili Therapeutics Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Appili Therapeutics Inc.

Location

21-1344 SUMMER ST.

Halifax, England, United Kingdom

About

Appili Therapeutics is an infectious disease biopharmaceutical company that is purposefully built, portfolio-driven, and people-focused to fulfill its mission of solving life-threatening infections. By systematically identifying urgent infections with unmet needs, Appili’s goal is to strategically develop a pipeline of novel therapies to prevent deaths and improve lives.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Appili Therapeutics Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Appili Therapeutics Inc.'s next move

See what Strategic adds

Appili Therapeutics Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.